| ²é¿´: 1177 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
yetta_he½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Çë°ïÎÒ·ÒëÏÂÕâ¶Î£¨Ó¢Ò뺺£©ÊµÔÚ²»¶®Õâ¸ö¼ì²âÐÐÒµµÄ£¬Ð»Ð»ÁË¡£
|
|
|
Practical Monitoring and Coagulation Laboratory Insights Coagulation Laboratory Considerations Coagulation testing is used in a variety of settings: screen for factor deficiencies (PT/ aPTT), monitoring drug efficacy (PT/aPTT), and exclude disease states (D-dimer). Variables affecting coagulation testing include preanalytical (e.g., timing of blood collection, processing, timing, and suitability) and analytical (e.g., instrument and reagent systems), which may impact the accuracy of the reported result. These variables can lead to notable differences in reported results between laboratories and should be taken into consideration when using observations in the literature or from an outside hospital, and in developing or adjusting the anticoagulant management plan. Lastly, the laboratory evaluation/testing should be interpreted as a surrogate marker of the hemostasis process, as these data may not be an absolute reflection of in vivo coagulation or hard outcomes. |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
277²ÄÁÏ¿ÆÑ§Ó빤³Ì080500Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ѧУÒѾÌá½»µ½NSFC£¬»¹ÄÜÐÞ¸ÄÂð£¿
ÒѾÓÐ9È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ7È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏѧ˶301·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
278Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÇóÖú
ÒѾÓÐ5È˻ظ´
yetta_he
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1127.3
- ºì»¨: 1
- Ìû×Ó: 175
- ÔÚÏß: 95Сʱ
- ³æºÅ: 832645
- ×¢²á: 2009-08-22
- ÐÔ±ð: MM
- רҵ: ÌìȻҩÎﻯѧ
3Â¥2011-10-07 21:56:24
xiaokaizi
½ð³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 39
- Ó¦Öú: 6 (Ó×¶ùÔ°)
- ½ð±Ò: 5209.5
- É¢½ð: 2188
- ºì»¨: 8
- Ìû×Ó: 1415
- ÔÚÏß: 176.9Сʱ
- ³æºÅ: 1265018
- ×¢²á: 2011-04-14
- ÐÔ±ð: GG
- רҵ: ·ÂÉú²ÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
yetta_he(½ð±Ò+50, ·ÒëEPI+1): ºÜ¸Ðл 2011-10-07 21:56:54
|
¶Ô¼à²âºÍÄýѪʵÑéÊÒµÄʵÓüû½â ¶ÔÓÚÄýѪʵÑéÊÒµÄ˼¿¼ ÔںܶàÏîÄ¿ÖлáʹÓõ½ÄýѪ¼ì²â£ºÈ±ÏÝÒò×ӵIJéÕÒ£¨²¬/²¿·ÖÄýѪ»îøʱ¼ä£©£¬¼à²âÒ©ÎïµÄÁÆÐ§£¨²¬/²¿·ÖÄýѪ»îøʱ¼ä£©£¬ºÍ¼²²¡×´Ì¬µÄ±÷³ý£¨D -¶þ¾ÛÌ壩¡£Ó°ÏìÄýѪ¼ì²âµÄ±äÁ¿°üÀ¨·ÖÎöǰ£¨ÀýÈ磬ѪҺ²É¼¯ºÍ´¦Àíʱ¼ä£¬¼ÆÊ±£¬ºÍÊÊÓ¦ÐÔ£©ºÍ·ÖÎöÖУ¨ÀýÈ磬ÒÇÆ÷ºÍÊÔ¼Áϵͳ£©£¬ËùÒÔËûÃÇ¿ÉÄÜÓ°Ïìµ½²âÊÔ±¨¸æµÄ¾«¶È¡£ÕâЩ±äÁ¿¿ÉÄܻᵼÖÂʵÑéÊÒÖ®¼äµÄ²âÊÔ±¨¸æ½á¹û´æÔÚÏÔ×ŵIJîÒ죬Òò´ËÔڲο¼ÎÄÏ×»òÒ½ÔºµÄ¹Û²ì½á¹û£¬»òÕßÖÆ¶¨»òµ÷Õû¿¹Äý¼Æ»®´ëʩʱ£¬Ó¦µ±½«ÕâЩ±äÁ¿µÄÓ°Ï쿼ÂÇÔÚÄÚ¡£×îºó£¬ÕâЩÊý¾Ý¿ÉÄܲ»»áÈ«ÃæµÄ·´Ó³ÌåÄÚÄýѪ»ò½á¹ûµÄÕæÊµÐÔ£¬ËùÒÔÖ»Ó¦°ÑʵÑéÊÒÆÀ¹À/²âÊÔµ±×÷ֹѪ¹ý³ÌÖеÄÌæÖ¸Ê¾Æ÷À´Àí½â¡£ ºÇºÇ£¬ÍâÐеİÑÄãµÄÎÄÏ׿´¶®ÁË£¬µ«ÊÇ£¬£¬×¢ÒâÀ¨ºÅÄÚµÄÓ¢Óï²»ÖªµÀ·ÒëÕýÈ·Óë·ñ£¬ |
2Â¥2011-10-07 20:28:41













»Ø¸´´ËÂ¥